To the full analysis
Buyback calculator for Inspire Medical Systems
Inspire Medical Systems stock: key metrics
INSPInspire Medical Systems had an operating margin of 5.6% and a return on invested capital (ROIC) of 13% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2015 | 64.9% | −247.1% | −266.3% |
| 2016 | 76.2% | −105.0% | −112.8% |
| 2017 | 78.9% | −56.0% | −61.3% |
| 2018 | 80.1% | −40.3% | −43.1% |
| 2019 | 83.4% | −42.5% | −40.5% |
| 2020 | 84.7% | −48.7% | −49.6% |
| 2021 | 85.7% | −17.1% | −18.0% |
| 2022 | 83.8% | −11.7% | −11.0% |
| 2023 | 84.5% | −6.4% | −3.4% |
| 2024 | 84.7% | 4.5% | 6.7% |
| 2025 | 85.4% | 5.6% | 15.9% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2015 | 0.0% | no data | 0.0% |
| 2016 | 200.0% | no data | −100.0% |
| 2017 | −100.0% | −93.4% | −69.8% |
| 2018 | −13.3% | −15.6% | −10.9% |
| 2019 | −23.8% | −15.6% | −18.3% |
| 2020 | −24.9% | −20.9% | −20.3% |
| 2021 | −18.4% | −84.3% | −14.2% |
| 2022 | −9.0% | −9.8% | −7.9% |
| 2023 | −3.7% | −32.1% | −3.1% |
| 2024 | 7.8% | 16.0% | 6.6% |
| 2025 | 18.6% | 13.0% | 16.0% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 13 Feb 2026)
- Valuation signal Fairly valued since 11 Nov 2026, previously Overvalued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.